{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"}],"units":"Participants"}],"description":"Number of participants in whom the voice prosthesis was considered feasible in the short-term with regards to clinical and technical aspects as judged by patient and investigator.","groups":[{"description":"A group of laryngectomized Provox ActiValve users tested the Provox Vega 22.5 French voice prosthesis for 3 weeks.","id":"OG000","title":"Provox Vega 22.5 French"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"3 weeks","title":"Short-term Feasibility Provox Vega 22.5 French","type":"PRIMARY","unitOfMeasure":"Patients"}